DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Anzemet (Dolasetron Mesylate Monohydrate) - News

 
 



News related to Anzemet (Dolasetron) and/or conditions it is approved for

FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy
Source: Cancer / Oncology News From Medical News Today [2014.10.14]
The U.S. Food and Drug Administration has approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in patients undergoing cancer chemotherapy.

Nausea and Vomiting
Source: MedicineNet Anaphylaxis Specialty [2014.07.09]
Title: Nausea and Vomiting
Category: Diseases and Conditions
Created: 1/31/2005 8:21:00 AM
Last Editorial Review: 7/9/2014 12:00:00 AM

FDA Gives Nod to Eisai's Antiemetic Combo
Source: MedPage Today Oncology/Hematology [2014.10.10]
(MedPage Today) -- Fixed-dose NEPA (Akynzeo) prevented chemotherapy-induced nausea and vomiting in the acute and late phases

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014